Rhaeos, Inc. Receives FDA Breakthrough Device Designation for FlowSense(TM) Noninvasive Thermal Sensor

Novel wireless device designed to optimize shunt management in patients with hydrocephalus EVANSTON, Ill., June 1, 2020 -- (Healthcare Sales & Marketing Network) -- Rhaeos, Inc. (Rhaeos), a private medical technology company focused on addressing a cli... Devices, Monitoring, Neurosurgery, FDA Rhaeos , FlowSense, ventricular shunt, hydrocephalus
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news